Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mick J. Daniel"'
Publikováno v:
Clinical Pharmacokinetics. 36:41-50
The objective of this study was to assess the potential of zanamivir, a specific inhibitor of influenza A and B virus neuraminidase, to interact with other coadministered therapies in the clinical setting.Potential interactions with zanamivir were ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9d714f2a082dfd786168888b6ea1fe
https://doi.org/10.2165/00003088-199936001-00005
https://doi.org/10.2165/00003088-199936001-00005
Autor:
Andy J. Harker, Elizabeth K. Hussey, Susan T. Hall, Mick J. Daniel, Gary L. Evans, Karl H. Donn
Publikováno v:
The Journal of Clinical Pharmacology. 34:975-977
3TC is a dideoxy-nucleoside analogue that has demonstrated in-vitro activity against human immunodeficiency virus (HIV). 3TC concentrations in humans were predicted before the initiation of clinical trials by interspecies scaling of pharmacokinetic p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66787afc8fc417cba9d64cfecdd40001
https://doi.org/10.1002/j.1552-4604.1994.tb01968.x
https://doi.org/10.1002/j.1552-4604.1994.tb01968.x
Publikováno v:
Clinical Pharmacokinetics; 1999 Supplement, Vol. 36 Issue 6, p41-50, 10p
Publikováno v:
Journal of Labelled Compounds & Radiopharmaceuticals; Jun1996, Vol. 38 Issue 6, p585-589, 5p
Autor:
Hussey, Elizabeth K., Donn, Karl H., Daniel, Mick J., Hall, Susan T., Harker, Andy J., Evans, Gary L.
Publikováno v:
Journal of Clinical Pharmacology; Oct1994, Vol. 34 Issue 10, p975-977, 3p